DKSH, the leading Market Expansion Services provider with a focus on Asia, is continuing its success story with Dr. Wolff-Gruppe, a German research-based consumer health company, to drive sales of its hair care products Alpecin and Plantur in Hong Kong and Taiwan.
HONG KONG, Nov. 5, 2014 /PRNewswire/ — DKSH Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, will provide registration, importation, sales, distribution, logistics and collection services for the Alpecin and Plantur products in Hong Kong and Taiwan.
The foundation of the relationship between DKSH Hong Kong and Dr. Wolff was laid in January 2013, when the companies signed an agreement to market Alpecin, a famous hair brand that is clinically proven to prevent hair loss. With a strong sales record, the successful relationship in Hong Kong has now been extended to additionally include the Plantur product range, specially tailored for women to help prevent sparse hair and hair loss.
In addition, DKSH will drive Dr. Wolff’s geographic expansion into Taiwan by marketing and distributing Alpecin into modern trade channels across the country.
"The extension of our partnership with DKSH to enter Taiwan and expand our portfolio in Hong Kong shows our confidence in the collaboration. The business performance of our brand in the Hong Kong market has been tremendously successful. There is no doubt that the strategic thinking and diligent operation of the team in DKSH have contributed to the substantial growth and penetration of our brand in the local market," said Eduard R. Dorrenberg, Managing Director, Dr. Wolff-Gruppe.
"It is our honor to work with Dr. Wolff and expand our collaboration in Hong Kong and into Taiwan. The market share of Dr. Wolff in Hong Kong has in a very short period of time grown to a leadership position in the anti-hair loss category. With our in-depth understanding of the local consumer markets and broad capabilities, we will help both Alpecin and Plantur expand in the way that best fit the local shopping behavior and retail environment," said Teresa Chen, Regional Vice President, Business Unit Healthcare, DKSH Hong Kong, Korea and Taiwan.
DKSH also provides Market Expansion Services to the company in Singapore. The extended partnership will further strengthen DKSH’s market position in the consumer health market while contributing incrementally to the Group’s overall earnings and profitability over time.
About Dr. Wolff-Gruppe
In its 109-year-old history, the family-run Dr. Wolff-Gruppe has just seen its most successful year ever. New scientific developments and modern innovations characterize the medium-sized enterprise. Thanks to clinical studies, it was proven in 2004 that through Alpecin shampoo, caffeine manages to reach the hair root and consequently stimulates hair growth. With newly developed markets in Europe and Asia as well as with new innovative products, the group managed to increase its turnover for a ninth time in a row, a new record. In 2013 and for the first time ever, the turnover was more than 200 million Euros.
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 735 business locations in 35 countries — 710 of them in Asia — and 27,200 specialized staff, DKSH generated net sales of CHF 9.6 billion in 2013.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices. With 150 business locations in 14 countries and around 9,050 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales of around CHF 4.3 billion in 2013.